LLY - Schrödinger extends collab for drug discovery tech with Lilly provides 2024 updates
2024-01-08 08:24:10 ET
More on Schrödinger
- Schrodinger Appears To Be Losing Momentum
- Schrodinger: Attractive Risk-Reward
- Schrödinger Q3 2023 Earnings Call Transcript
- KeyBanc sees opportunity in tech-enabled drug discovery stocks
- Schrödinger GAAP EPS of -$0.86 misses by $0.17, revenue of $42.6M beats by $4.75M
For further details see:
Schrödinger extends collab for drug discovery tech with Lilly, provides 2024 updates